SNHG17 has emerged as an oncogene in several cancer types, including colorectal cancer, hepatocellular carcinoma, gastric cancer, and breast cancer, as it exhibits increased expression levels in these tumor types [22–25]. Here, SNHG17 is linked to cancer.